We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Market high

13 June 2017 By Robyn Mak

Shares of WuXi Biologics, the city’s biggest listing this year, popped as much as 39 pct on their debut. High earnings growth and a lack of exciting IPOs led to strong demand for the $511 mln deal. This is good news for a bourse keen to attract a new breed of entrepreneurs.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)